| Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883) | 
|---|
| 06/22/1995 | CA2138509A1 Methods of inhibiting autoimmune diseases | 
| 06/22/1995 | CA2138508A1 Methods for inhibiting ldl oxidation and atherosclerosis | 
| 06/22/1995 | CA2138507A1 Methods of inhibiting sexual precocity | 
| 06/22/1995 | CA2138506A1 Methods of inhibiting male infertility | 
| 06/22/1995 | CA2138505A1 Methods of inhibiting the symptoms of premenstrual syndrome/late luteal phase dysphoric disorder | 
| 06/22/1995 | CA2138501A1 Methods of inhibiting breast disorders | 
| 06/22/1995 | CA2138500A1 Methods of inhibiting ovarian dysgenesis, delayed puberty, or sexual infantilism | 
| 06/22/1995 | CA2138499A1 Methods for inhibiting vasomotor symptoms and attending psychological disturbances surrounding post-menopausal syndrome | 
| 06/22/1995 | CA2138498A1 Methods of inhibiting hirsutism and alopecia in women | 
| 06/22/1995 | CA2138497A1 Method for increasing libido in post-menopausal women | 
| 06/22/1995 | CA2138496A1 Methods of inhibiting pulmonary hypertensive diseases | 
| 06/22/1995 | CA2138495A1 Methods of inhibiting alzheimer's disease | 
| 06/22/1995 | CA2138494A1 Methods of inhibiting turner's syndrome | 
| 06/22/1995 | CA2138493A1 Methods of inhibiting thrombin | 
| 06/22/1995 | CA2138492A1 Methods of increasing macrophage function | 
| 06/22/1995 | CA2138491A1 Methods of inhibiting seborrhea and acne | 
| 06/22/1995 | CA2138490A1 Methods of increasing thrombomodulin expression | 
| 06/22/1995 | CA2138459A1 Methods of inhibiting cns problems in post-menopausal women | 
| 06/22/1995 | CA2138458A1 Methods of inhibiting obsessive-compulsive and consumptive disorders | 
| 06/22/1995 | CA2138457A1 Non-peptide tachykinin receptor antagonists | 
| 06/22/1995 | CA2138456A1 Methods of inhibiting fertility in women | 
| 06/22/1995 | CA2138455A1 Methods for inhibiting weight gain or inducing weight loss | 
| 06/22/1995 | CA2138454A1 Methods of inhibiting imperfect tissue repair | 
| 06/22/1995 | CA2138100A1 Methods of treating menstrual symptoms and compositions therefor | 
| 06/21/1995 | EP0658553A1 Polycyclic aromatic compounds, pharmaceutical compositions containing them and uses thereof | 
| 06/21/1995 | EP0658539A1 Excitatory amino acid receptor antagonists | 
| 06/21/1995 | EP0658348A2 Aqueous solution inclusion complexes of benzothiophene compounds with cyclodextrins | 
| 06/21/1995 | CN1028988C Certain glyoxyl-cyclohexendions | 
| 06/20/1995 | US5426225 Chemical intermediate of 2-perfluoroalkyl-3-oxazolin-5-one | 
| 06/20/1995 | US5426211 Vinyl 2-aryl-propionates | 
| 06/20/1995 | US5426191 Process for the synthesis of 3-chlorobenzo[b]thiophene-2-carbonyl chlorides | 
| 06/20/1995 | US5426091 Herbicidal compounds | 
| 06/16/1995 | CA2138181A1 Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension | 
| 06/16/1995 | CA2137897A1 Biaromatic compounds derived from amides; pharmaceutical and cosmetic compositions containing the same and their uses | 
| 06/16/1995 | CA2137896A1 Propynyl biaromatic compounds; pharmaceutical and cosmetic compositions containing the same and their uses | 
| 06/16/1995 | CA2137739A1 Polycyclic aromatic compounds; pharmaceutical and cosmetic compositions containing the same and their use | 
| 06/15/1995 | WO1995015752A1 Diphenyl-2-propenoates and homologs thereof useful for treating diseases associated with leukotriene b4 | 
| 06/15/1995 | CA2178634A1 Diphenyl-2-propenoates and homologs thereof useful for treating diseases associated with leukotriene b4 | 
| 06/15/1995 | CA2137533A1 Aqueous solution inclusion complexes of benzothiophene compounds with water soluble cyclodextrins, and pharmaceutical formulations and methods thereof | 
| 06/14/1995 | EP0657419A1 Alcohols | 
| 06/14/1995 | EP0657162A1 Methods for lowering serum cholesterol | 
| 06/14/1995 | EP0656887A1 Hydroxyethylamino sulfonamides useful as retroviral protease inhibitors | 
| 06/13/1995 | US5424448 Preparation of carbonic anhydrase inhibitors | 
| 06/13/1995 | US5424447 Inhibitors of nitric oxide formation from arginine | 
| 06/13/1995 | US5424333 Anthelmintic N'-substituted-N,N'-disubstitutedhydrazines | 
| 06/13/1995 | US5424325 Aminoketone derivatives | 
| 06/13/1995 | US5424313 Bibyclic heteroacrylpiperazine derivatives having psychotropic activity, and pharmaceutical compositions containing these derivatives | 
| 06/08/1995 | WO1995015323A1 IMPROVED PROCESS FOR THE SYNTHESIS OF 3-CHLOROBENZO[b]THIOPHENE-2-CARBONYL CHLORIDES | 
| 06/08/1995 | CA2172382A1 Improved process for the synthesis of 3-chlorobenzo[b]thiophene-2-carbonyl chlorides | 
| 06/07/1995 | EP0656345A1 Aspartic acid derivatives or homologues thereof and their use in the treatment of neurological diseases | 
| 06/07/1995 | EP0655996A1 Substituted benzylamino nitrogen containing non-aromatic heterocycles | 
| 06/07/1995 | EP0655995A1 Cyclohexenonoxime ethers, their preparation and their use | 
| 06/06/1995 | US5422373 Anti-atherosclerotic aryl compounds | 
| 06/06/1995 | US5422359 α-aminoketone derivatives | 
| 06/06/1995 | US5422335 Plant growth regulators | 
| 06/04/1995 | CA2137028A1 Pharmaceutical compounds | 
| 06/04/1995 | CA2136904A1 Excitatory amino acid receptor antagonists | 
| 06/02/1995 | CA2136789A1 Methods of inhibiting the effects of amyloidogenic proteins | 
| 06/01/1995 | WO1995014652A1 Novel triphenylene compounds and process for producing discoidally liquid crystalline cross-linked polymers | 
| 05/31/1995 | EP0655439A2 5,6-Bicyclic glycoprotein IIb IIIa antagonists useful in inhibition of platelet aggregation | 
| 05/31/1995 | EP0655055A1 Tachykinin antagonists | 
| 05/31/1995 | CN1028645C Free-radical polymerization composition | 
| 05/30/1995 | US5420349 2-amino-3-aroyl-benzo[β]thiophenes and methods for preparing and using same to produce 6-hydroxy-2-(4-hydroxyphenyl)-3-]benzo[4-(2-aminoethoxy)-benzoyl[β]thiophenes | 
| 05/30/1995 | US5420333 Lignan analogues, methods of preparation thereof and anti-hyperlipemic agents | 
| 05/30/1995 | US5420300 Chemical intermediate for leukotriene inhibitor | 
| 05/30/1995 | US5420164 Enzyme inhibitors | 
| 05/30/1995 | US5420163 Use of acyl urea compounds for controlling endoparasites and ectoparasites of warm-blooded animals | 
| 05/30/1995 | US5420159 Pesticides, insecticides for plants and animals | 
| 05/30/1995 | US5420153 Tetronic, thiotetronic and tetramic acid derivatives as phospholipase A.sub. | 
| 05/26/1995 | WO1995014017A1 Non-peptide tachykinin receptor antagonists | 
| 05/26/1995 | WO1995014015A1 Benzothiophene derivatives possessing a methoxyimino substituent as microbicides | 
| 05/26/1995 | CA2176735A1 Non-peptide tachykinin receptor antagonists | 
| 05/24/1995 | EP0654264A1 Treatment of incontinence with venlafaxine or an aryloxy propanamine compound | 
| 05/24/1995 | CN1102849A Isoparaffin-olefin alkylation | 
| 05/23/1995 | US5418252 Method for inhibiting cartilage degradation | 
| 05/23/1995 | CA1335672C Thioformamide derivatives | 
| 05/18/1995 | WO1995013276A1 Novel thiophenesulfonylurea derivatives and herbicidal composition containing the same | 
| 05/18/1995 | WO1995013262A1 Substituted phenyl compounds | 
| 05/18/1995 | CA2176363A1 Substituted phenyl compounds | 
| 05/18/1995 | CA2175819A1 Novel thiophenesulfonylurea derivatives and herbicidal composition containing the same | 
| 05/17/1995 | EP0497816B1 Treatment of hiv infections and compounds useful therein | 
| 05/17/1995 | CN1028429C Method for preparing of substd. Thieno (2,3-B)(1,5) benzodiazepine derivatives | 
| 05/16/1995 | US5416223 Iodinated esters | 
| 05/16/1995 | US5416117 Cyclopropenone derivatives | 
| 05/16/1995 | US5416103 N-cyclohex(en)yl-pyridine carboxamides and compositions containing them for controlling fungal pests | 
| 05/16/1995 | US5416068 Alpha-phenylacrylic acid derivatives, their preparation and their use for controlling pests and harmful fungi | 
| 05/16/1995 | CA1335593C Thieno [2,3-d]azepine derivatives, process for their preparation and pharmaceutical compositions thereof | 
| 05/16/1995 | CA1335590C Anhydrous, crystalline sodium salt of 5-chloro-3-(2-thenoyl)-2-oxindole-1-carboxamide | 
| 05/13/1995 | CA2134192A1 5, 6-bicyclic glycoprotein iib/iiia antagonists | 
| 05/11/1995 | WO1995012589A1 Process for the preparation of n-4-[(substituted phenyl)alkylthienyl]-, and n-4-[(substituted phenyl)alkylfuryl]but-3-yn-2-yl]-n-hydroxyurea compounds | 
| 05/11/1995 | WO1995012572A1 Cyclobutane derivatives as inhibitors of squalene synthetase and protein farnesyltransferase | 
| 05/11/1995 | CA2174548A1 Process for the preparation of n-4-¬(substituted phenyl)alkylthienyl|-, and n-4-¬(substituted phenyl)alkylfuryl|but-3-yn-2-yl|-n-hydroxyurea compounds | 
| 05/11/1995 | CA2152822A1 Cyclobutane derivatives as inhibitors of squalene synthetase and protein farnesyltransferase | 
| 05/10/1995 | EP0652208A1 Phenylalkan(en)oic acids with leukotriene B4 antagonistic activity | 
| 05/10/1995 | EP0652005A1 Methods for inhibiting endometriosis | 
| 05/10/1995 | EP0652004A1 Methods for treating resistant neoplasms | 
| 05/10/1995 | EP0652003A1 Methods for inhibiting smooth muscle cell proliferation and restinosis | 
| 05/10/1995 | EP0652002A1 Methods for inhibiting cartilage degradation | 
| 05/10/1995 | EP0652001A1 Methods for treating per-menopausal syndrome | 
| 05/10/1995 | EP0652000A1 Methods for inhibiting angiogenisis and angiogenic diseases |